September 24, 2026
john-wilkerson-avatar-teal
Washington Correspondent, D.C. Diagnosis Writer

If you were at the Capitol yesterday and lost a thong, you can call the United States Capitol Police Lost & Found at (202) 225-4200. Send news tips to John.Wilkerson@statnews.com or John_Wilkerson.07 on Signal, but please, keep your undies.

fda commissioner nominee

Trump’s pick for FDA faces senators

Today is the big day for 37-year-old Heidi Overton who, if confirmed, would be the youngest person to lead the FDA, beating out Mark McClellan, who was 39 when he became the FDA commissioner during the George W. Bush administration.

Overton is a physician board-certified in public health and general preventive medicine. She has the backing of McClellan and Scott Gottlieb, who ran the agency during Trump’s first term. Republican stalwart Newt Gingrich and former Louisiana Gov. Bobby Jindal, who served as the principal adviser to the HHS secretary under Bush, also support her.

“Wise beyond her years,” “sharp,” “calm,” “bound by her faith,” “ soft-spoken,” “always right”: those are some of the many ways people interviewed by Margaret Manto described Overton.

But she will no doubt face tough questions at today’s Senate confirmation hearing about abortion and her support for health secretary Robert F. Kennedy Jr.’s attack on vaccines.

Follow along with our live blog of the hearing, check out what Gottlieb and McClellan have to say about her, and read more about Overton’s medical background, White House policy role, and career trajectory from a childhood in rural New Mexico to FDA commissioner nominee.



confirmation hearing

Overton plans to ‘go fast’

At today's hearing, Overton will emphasize the need for speed and efficiency at the FDA to compete with China’s accelerating biotechnology industry, according to prepared remarks that Margaret obtained.

Overton says she is committed to continuing the work the administration began earlier this year to speed up the clinical trial process.

Her statement only references vaccines in passing, and there is no mention of her involvement in the recent changes to the childhood vaccine schedule, which health committee chair Sen. Bill Cassidy (R-La.) called “almost disqualifying.”

Read more of Margaret’s scoop about Overton's opening statement.


physician payment

Crying uncle on doctor pay reform

Congress is finally warming to the first major overhaul of how Medicare pays doctors in more than a decade.

The main measure under consideration would link Medicare’s doctor pay rates to a medical inflation measure, giving doctors guaranteed pay boosts, as hospitals and other parts of the health care system have long received.

In doing so, Congress would be retreating from the notion that Medicare can control how many services physicians provide on a national basis, an idea that has undergirded Medicare’s doctor payments for decades. And it would reduce the government’s push to get clinicians to engage in value-based care, where they get paid more to keep patients healthy.

Read more.


hospitals

Why a private-equity owned hospital chain is becoming a nonprofit

Is it a private-equity bailout or a lifeline for rural hospitals?

That’s the underlying question in this in-depth article by Tara Bannow about Quorum Health, a private equity-owned chain of mostly rural hospitals that’s converting to a nonprofit organization.

It’s a fascinating move. Individual private equity-owned hospitals have transitioned to nonprofit status before, but it’s unheard of for an entire chain to do so.

Read more about the potential upsides and downsides of the transition and why Moody’s Investors Service describes Quorum’s capital structure as “unsustainable.”


medical devices

How to pay for remote patient monitoring devices

Major insurers are at odds over a Medicare proposal that would significantly disrupt how many doctors bill for tracking the health of patients using devices like connected blood pressure cuffs, scales, and blood glucose meters, Mario Aguilar reports.

UnitedHealth Group, CVS Health, and Kaiser Permanente oppose a Medicare proposal that would effectively ban providers from using contractors to deliver remote patient monitoring care. Those companies operate both insurers and care organizations.

Humana and the Blue Cross Blue Shield Association, in contrast, support Medicare’s proposal.

Read more about what their differences could mean for coverage of the devices.


research funding

White House backs off controversial NIH order

The Trump administration seems to be retreating from an executive order that would give the White House more influence over grants at the National Institutes of Health, Anil Oza and Chelsea Cirruzzo report.

The order would create a commission of political appointees, including White House Office of Management and Budget Director Russell Vought. It met with pushback from many lawmakers in both parties, including Appropriations Committee Chair Susan Collins (R-Maine).

The order is the latest attempt by the administration to politicize science funding. Read more.


More around STAT

What we’re reading

  • HHS unveils new initiatives to reduce animal testing in drug development, STAT
  • A Western Mass. lesbian bar required KN-95 masks. When it changed the rules, all hell broke loose, The Boston Globe
  • Flagship gets a Pentagon contract, STAT
  • Opinion: I’m a Republican senator. America needs more science, not less, The Washington Post
  • Trump boast on drug pricing policy overstated state-level interest in federal program, STAT